Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • Biotechnology
  • Australian biopharma Clinuvel to shed up to 20% of workforce in move to US

Australian biopharma Clinuvel to shed up to 20% of workforce in move to US

July 23, 2026Posted inBiotechnology

Australian biopharma Clinuvel Pharmaceuticals is moving its headquarters to the U.S.— but up to a fifth of the company’s workforce won’t be staying for the trans-Pacific pivot.

Post navigation

Previous Post
Roche drops TCE for lupus, but hasn’t given up on autoimmune cell therapies
Next Post
Roche Diagnostics growth remains muted amid China headwinds

Recent Posts

  • Excessively Dilated Kidneys Face Higher Surgical Risks in Children
  • Cancer cells evade death via network-level plasticity
  • ARL6IP4 Linked to Osteoarthritis in Activated T Cells
  • Language Models Show High Consistency and Divergent Profiles Across Personality Assessments
  • Social Matrix Framework Links Heritage Tree Persistence to Interconnected Community Stewardship Systems

Archives

  • November 2026
  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • September 2024
  • August 2024
  • March 2024
  • September 2023

Privacy Policy    Terms

Scroll to Top